Skip to main content
. 2022 May 30;12:895022. doi: 10.3389/fcimb.2022.895022

Figure 4.

Figure 4

AMK+BIO-PLY treatment altered cellular populations in the synovial fluid and systemic biomarkers. (A–D) Synovial fluid total nucleated cell count, total protein, neutrophil percentage, and mononuclear cell percentage. (E–H) Systemic leukocyte count, fibrinogen concentration, D-dimer concentration, and Serum Amyloid A concentration. Means and standard deviations of each group (control vs treatment; n=6), and significant differences *p<0.05 **p<0.01 ***p<0.001 ****p<0.0001 were determined by the paired t-tests comparing control and treatment at each day.